Stemcis

Since 2015, STEMCIS has joined the DMS group in which the Biotech branch was created. STEMCIS has a strong experience and expertise on adipose tissue , adipose mesenchymal stem cells and their use in plastic and reconstructive surgery . This high expertise in adipose tissue allows the company to develop surgical kits for the collection, treatment and re-injection of fat cell preparations. These kits are Class IIa medical devices, associated with a specific protocol, on the latest research and developed according to the intended therapeutic use. STEMCIS is also interested in the use of adipose tissue and its cellular derivatives in human regenerative medicine. Co-founders